Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINMON Study of Sofosbuvir/Velpatasvir in HCV Patients
NCT03512210Phase 4Completed
- Start
- Oct 2018
- Primary completion
- Jul 2020
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C (HCV). Started Oct 2018; status: completed.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03512210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512210.